You are here:
GAVI support for new and underused vaccines has contributed to the immunisation of an additional 370 million children.
GAVI plans to support the rollout of pneumococcal vaccines in over 40 countries by 2015.
Ten GAVI-eligible countries have added rotavirus vaccine to their immunisation programmes.
MenAfriVac vaccine could prevent 150,000 deaths by 2015 in Africa's "meningitis belt".
One health plan, One budget, One joint assessment, One tracking system for funds.
Countries use GAVI's HSS funding to target 'bottlenecks' in their health system.
CSOs can reach the 10-20% of communities beyond the reach of health services.
No upcoming events for this calendar
Forty-three percent of GAVI vaccines are produced by pharmaceutical companies based in emerging markets.
© GAVI Alliance 2013
modal window here